New Strategies for Targeting CTLA-4 Emerge
In 2011, the development of ipilimumab, a novel antibody targeting the CTLA-4 immune checkpoint, helped launch the modern era of anticancer immunotherapy.
Source: onclive.com
Page 22 - Accessed May News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Accessed May Today - Breaking & Trending Today
US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making | Business
PHILADELPHIA--(BUSINESS WIRE)--Jun 21, 2023--
Source: valdostadailytimes.com
Ensuring Access to Vaccinations Among Older Adults and Underserved Populations
A broader understanding of vaccine hesitancy and barriers has helped to enhance acceptance of vaccination services through educational outreach.
Source: pharmacytimes.com
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific posters detailing...
Source: prnewswire.com
Lundbeck to Present New Clinical and Real-World VYEPTI® (eptinezumab-jjmr) Data at the 65th Annual S
First-time presentation of a real-world evidence study that revealed high overall satisfaction with the effectiveness of VYEPTI treatment for chronic migraine among most patients and their treating neurologists, as well as positive infusion experienceHarris Poll Migraine Report Card Survey uncovers racial and ethnic...
Source: pharmiweb.com